Raptor inhibitors belong to a distinct chemical class that has garnered significant attention in the field of biomedical research. These compounds specifically target a protein known as Raptor, which plays a crucial role in the regulation of cellular processes. Raptor, also known as Regulatory-Associated Protein of mTOR, is a key component of the mechanistic target of rapamycin complex 1 (mTORC1), a signaling pathway that governs various cellular functions, including cell growth, metabolism, and protein synthesis. The chemical structure of raptor inhibitors is meticulously designed to bind selectively to the active site of Raptor, preventing its interaction with other proteins and disrupting the normal functioning of the mTORC1 pathway. This targeted inhibition of Raptor activity effectively modulates downstream signaling events, resulting in the alteration of cellular processes that rely on mTORC1 activity.
The discovery and development of raptor inhibitors have provided valuable insights into the intricate regulatory mechanisms governing cellular physiology. By specifically inhibiting Raptor, researchers can probe the intricate network of molecular interactions orchestrated by the mTORC1 pathway. This enables a deeper understanding of the fundamental processes that drive cell growth, metabolism, and protein synthesis, shedding light on the intricate mechanisms underlying various physiological and pathological conditions. Researchers have extensively studied raptor inhibitors in a range of experimental models, utilizing them as valuable tools for elucidating the complex roles of mTORC1 signaling in both normal and disease states. Overall, raptor inhibitors represent a significant advancement in the field of molecular biology and cellular signaling research. By selectively targeting Raptor and modulating the activity of the mTORC1 pathway, these compounds provide a valuable tool for unraveling the intricacies of cellular processes and paving the way for future discoveries in basic and translational science.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Sirolimus was one of the first mTORC1 inhibitors discovered and has been used as an immunosuppressant drug in transplantation and for certain cancers. | ||||||
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $131.00 $651.00 | 7 | |
Everolimus is found in sirolimus and has similar applications, including as an immunosuppressant and anticancer agent. | ||||||
Ridaforolimus | 572924-54-0 | sc-212783 | 5 mg | $248.00 | 1 | |
Ridaforolimus is an investigational drug being studied for its potential anticancer effects. | ||||||
AZD2014 | 1009298-59-2 | sc-364420 | 5 mg | $303.00 | 2 | |
AZD2014 is a mTORC1/mTORC2 dual inhibitor under investigation for its potential in various cancers. | ||||||
INK 128 | 1224844-38-5 | sc-364511 sc-364511A | 5 mg 50 mg | $321.00 $1835.00 | ||
MLN0128 is an investigational mTOR kinase inhibitor with potential applications in cancer research. | ||||||
OSI-027 | 936890-98-1 | sc-364557 sc-364557A | 10 mg 50 mg | $437.00 $1186.00 | 1 | |
OSI-027 is a dual mTORC1/mTORC2 inhibitor that has been studied for its effects on cancer cells. | ||||||
Torin 1 | 1222998-36-8 | sc-396760 | 10 mg | $245.00 | 7 | |
Torin1 is a potent and selective mTORC1 and mTORC2 inhibitor used in research settings. | ||||||
WYE-687 | 1062161-90-3 | sc-364653 sc-364653A | 10 mg 50 mg | $235.00 $992.00 | ||
WYE-687 is an mTOR kinase inhibitor that has shown promise in research studies for cancer research. | ||||||